CRP and chronic kidney disease: Finally, a recent study concluded that the 11β-HSD-mediated glucocorticoid activation in T2D is determined by inflammation (higher CRP) and is associated with diabetes and poorer glycaemic control in patients with CKD stages III–V (37).